This review updates the current status of immunology research under the influence of genomics,both conceptually and technologically.It particularly highlights the advantages of employing the high-throughput and large-...This review updates the current status of immunology research under the influence of genomics,both conceptually and technologically.It particularly highlights the advantages of employing the high-throughput and large-scale technology,the large genomic database,and bioinformatic power in the immunology research.The fast development in the fields of basic immunology,clinical immunology(tumor and infectious immunology) and vaccine designing is illustrated with respect to the successful usage of genomic strategy.We also speculate the future research directions of immunology in the era of genomics and post-genomics.展开更多
针对中国合格评定国家认可委员会(China National Accreditation Service for Conformity Assessment,CNAS)的CNAS-CL39:2012实施一年多以来,在临床免疫检验评审中发现不符合项进行了原因分析,并提出合理的纠正措施,以帮助临床免疫实验...针对中国合格评定国家认可委员会(China National Accreditation Service for Conformity Assessment,CNAS)的CNAS-CL39:2012实施一年多以来,在临床免疫检验评审中发现不符合项进行了原因分析,并提出合理的纠正措施,以帮助临床免疫实验室更好地完善质量管理体系,持续进行质量改进,保证检验结果准确有效,更好地为临床提供优质服务,同时也为深入理解和落实CNAS-CL02:2012和CNAS-CL39:2012规则提供有益的借鉴。展开更多
基金Supported by the National High-Tech Research and Development Program of China (Grant No.2006AA02A252)National Natural Science Foundation of China (Grant No.30771965)Shanghai Pujiang Program (Grant No.07pj14066)
文摘This review updates the current status of immunology research under the influence of genomics,both conceptually and technologically.It particularly highlights the advantages of employing the high-throughput and large-scale technology,the large genomic database,and bioinformatic power in the immunology research.The fast development in the fields of basic immunology,clinical immunology(tumor and infectious immunology) and vaccine designing is illustrated with respect to the successful usage of genomic strategy.We also speculate the future research directions of immunology in the era of genomics and post-genomics.
文摘针对中国合格评定国家认可委员会(China National Accreditation Service for Conformity Assessment,CNAS)的CNAS-CL39:2012实施一年多以来,在临床免疫检验评审中发现不符合项进行了原因分析,并提出合理的纠正措施,以帮助临床免疫实验室更好地完善质量管理体系,持续进行质量改进,保证检验结果准确有效,更好地为临床提供优质服务,同时也为深入理解和落实CNAS-CL02:2012和CNAS-CL39:2012规则提供有益的借鉴。
